WE'RE LEADING A LANDMARK STUDY ON MOLECULAR TESTING FOR CHILDHOOD CANCER. Learn more.

New Research Funding
Your gift helps develop new treatments, faster. Because kids with cancer can't wait.

Your donation helps develop
new treatments, faster.

Your donation helps develop
new treatments, faster.

Your donation helps develop
new treatments, faster.

Because kids with cancer can't wait.

Because kids with cancer can't wait.

Because kids with cancer can't wait.

New Research Funding
Your gift helps develop new treatments, faster. Because kids with cancer can't wait.

Your gift helps develop
new treatments, faster.

Your gift helps develop
new treatments, faster.

Your gift helps develop
new treatments, faster.

Your gift helps develop
new treatments, faster.

Your gift helps develop
new treatments, faster.

Your gift helps develop
new treatments, faster.

Your gift helps develop
new treatments, faster.

Your gift helps develop
new treatments, faster.

Your gift helps develop
new treatments, faster.

Because kids with cancer can't wait.

Because kids with cancer can't wait.

Because kids with cancer can't wait.

Because kids with cancer can't wait.

Because kids with cancer can't wait.

Because kids with cancer can't wait.

Because kids with cancer can't wait.

Because kids with cancer can't wait.

Because kids with cancer can't wait.

AN URGENT UNMET NEED: Cancer is the #1 Disease Killer in Children

Fact:

Fact:

Fact:

AN URGENT UNMET NEED: Cancer is the #1 Disease Killer in Children

Fact:

Leaders from across pediatric cancer explain the urgent, critical need for new treatments, and how we're changing the odds for the 42 children diagnosed each day.

Leaders from across pediatric cancer explain the urgent, critical need for new treatments, and how we're changing the odds.

How your support is changing the odds

We focus on areas of unmet need

Every child deserves safe treatment.

We are dedicated to ensuring that every child diagnosed with cancer has a safe and effective treatment option. Focusing on pediatric cancers with insufficient or ineffective treatment options is a priority of our research strategy. Our unique funding strategy focuses on addressing areas of unmet need, including:

• Cancers with the lowest survival rates

• Limited or most damaging treatment options

• Populations that are underserved, including adolescents and young adults

Our unique funding strategy is delivering results

Our research funds groundbreaking, lifesaving breakthroughs.

CureSearch is armed with the best-in-class advisory councils that ensure research is engineered to advance to the marketplace. This accelerated research is quickly leading to new advancements, including:

A novel drug for Ewing sarcoma in pediatric clinical trials

A clinical trial for high-grade glioma that is now enrolling patients

A new treatment for recurrent, refractory medulloblastoma in pediatric clinical trials

Our projects are 7x more likely to advance

Speed is critical, because children with cancer can't wait.

60% of preclinical research projects funded through our Acceleration Initiative advance to clinical trials, compared to a less than 8% average rate of translation for drugs into clinical cancer trial. CureSearch-funded pre-clinical projects are 7x more likely to advance to clinical trials and get there 1.5x faster compared to the national average.

We ONLY fund translational research

A "bench to bedside" focus is critical.

There is a significant funding gap for translational, preclinical, and early-phase clinical trials. CureSearch only funds translational research projects with the strongest potential to become a new treatment and quickly reach patients. In the last 5 years, we’ve awarded more than $12 million in research grants for projects dedicated to developing new therapies for kids with cancer.

Simply put, if a project isn't on an accelerated path to new drug development, we don’t fund it.

Together, we are saving children's lives!

Our mission is to end childhood cancer by driving targeted and innovative research with measurable results in an accelerated time frame. The research we fund is delivering safer, more effective pediatric cancer treatments. Thank you for your support!

Read the latest impact report

Get Involved and Help End Children’s Cancer!

hike

Ultimate Hike

Tell children’s cancer to “take a hike” and join us for a life changing, lifesaving adventure on one of the country’s most iconic trails.

walk

CureSearch Walk

Form a team in your community, raise critical funds, and walk in honor of the 47 children diagnosed each day. Thanks to everyone who made the 2020 United CureSearch Walk possible. We hope you'll join us for the 2021 Walk. 

gold-c

CureSearch Gold

Create your own fundraising event to help end childhood cancer; from golf tournaments to backyard BBQ’s, the possibilities are endless!

challenge-c

CureSearch Challenge

Go the extra mile for your favorite race, join our team or snag an entry for one of our official teams at curesearchchallenge.org. The 2021 Winter Challenge is happening now! Visit curesearch.org/winterchallenge to join or learn more! 

fundraise

Volunteer Opportunities

Lend your time, skills, expertise and passion in support of our shared mission to end children’s cancer.

corporate

Corporate Partnerships

Engage your employees, customers and communities by partnering with us to help end children’s cancer.

Unmatched Expert Leadership

Our Scientific and Industry Advisory Councils are comprised of experts at the top of their fields, and validation of a research project by our Scientific Review Committee speaks volumes in the global pediatric cancer arena.

Led by Brenda Weigel, MD, MSc
The Scientific Advisory Council includes leading pediatric oncologists who set the academic priorities for CureSearch research initiatives and evaluate projects on scientific merit.
Led by Jeffrey Skolnik, MD
The Industry Advisory Council includes leaders from the largest global oncology and biotechnology companies who champion pediatric cancer programs and review potential research projects for clinical and regulatory feasibility.
Led by Stephan Sallan, MD
Our Scientific Review Committee provides rigourous peer review of research proposals, evaluating: scientific merits, innovation, unmet need and clinical impacts.

Our Corporate Partners

ironhill

"We’re proud to be a long-time partner of CureSearch with 10+ years of support for children’s cancer research. This relationship demonstrates to both the employees and customers of Iron Hill Brewery & Restaurant that we care deeply about the wider community that we serve. We know CureSearch is hard at work finding new treatment options for kids and together we are helping to put an end to childhood cancer."

Kevin Finn

Founder and President, Iron Hill Brewery & Restaurant
Kiewit

"Our annual Jakefest events honor the memory of my son, Jake, who passed away after a heroic fight with rhabdomyosarcoma. Kiewit has partnered with CureSearch because they're uniquely positioned to accelerate the pace of finding new drugs for kids. Through the generosity of Kiewit's employees, their spouses, friends, relatives, and our gracious business partners, over $3,000,000 has been raised for CureSearch. We could hardly have imagined twelve years ago the outpouring of goodwill this event has brought."

Harry Koenigs, Jake's Dad

Area Manager, Kiewit

Pin It on Pinterest

Scroll to Top